Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do GM1 antibodies induce demyelination?

D J Lange1, W Trojaborg

  • 1Neurological Institute Columbia-Presbyterian Medical Center, New York, New York 10032.

Muscle & Nerve
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Evidence of Baryogenesis and Dark Matter in B^{+}→ψ_{D}+p Decays at BABAR.

Physical review letters·2023
Same author

Search for an Axionlike Particle in B Meson Decays.

Physical review letters·2022
Same author

Search for Lepton Flavor Violation in ϒ(3S)→e^{±}μ^{∓}.

Physical review letters·2022
Same author

Search for Darkonium in e^{+}e^{-} Collisions.

Physical review letters·2022
Same author

Precision Measurement of the Ratio B(ϒ(3S)→τ^{+}τ^{-})/B(ϒ(3S)→μ^{+}μ^{-}).

Physical review letters·2021
Same author

Search for a Dark Leptophilic Scalar in e^{+}e^{-} Collisions.

Physical review letters·2020
Same journal

Join AANEM.

Muscle & nerve·2026
Same journal

Targeted Muscle Reinnervation for Management and Prevention of Symptomatic Neuroma.

Muscle & nerve·2026
Same journal

AANEM News & Insights.

Muscle & nerve·2026
Same journal

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
See all related articles

Multifocal motor neuropathy (MMN) mimics motor neuron disease (MND) but is distinguished by conduction block. While GM1 antibodies are implicated, many MMN patients lack them but still respond to immunosuppression, suggesting other antibodies may be involved.

Area of Science:

  • Neurology
  • Immunology
  • Neurophysiology

Background:

  • Multifocal motor neuropathy (MMN) is a disorder that clinically resembles motor neuron disease (MND).
  • MMN is characterized by multifocal conduction block (CB), identifiable through electrophysiological studies.
  • High titers of anti-ganglioside GM1 antibodies are sometimes associated with MMN.

Purpose of the Study:

  • To review clinical, neurophysiological, immunological, and experimental data on MMN.
  • To differentiate MMN from MND based on electrophysiological findings.
  • To explore the role of GM1 antibodies and other potential autoantibodies in MMN pathogenesis.

Main Methods:

  • Review of clinical data.
  • Analysis of neurophysiological findings, specifically electrophysiological evidence of conduction block.

Related Experiment Videos

  • Examination of immunological markers, including GM1 antibody titers.
  • Evaluation of experimental data related to MMN.

    • Main Results:

    • MMN is differentiated from MND by the presence of multifocal conduction block.
    • While high GM1 antibody titers are observed in some MMN cases, 70% of patients lack elevated titers.
    • A significant proportion of MMN patients without elevated GM1 antibodies respond to immunosuppressive treatment.

    Conclusions:

    • The presence of multifocal conduction block is a key diagnostic feature distinguishing MMN from MND.
    • The immunopathogenesis of MMN may involve antibodies other than anti-GM1, potentially targeting different epitopes in the paranodal region.
    • Further research is needed to identify the specific autoantibodies responsible for conduction block in MMN patients who are seronegative for GM1 antibodies.